“Hot cross bun” is a potential imaging marker for the severity of cerebellar ataxia in MSA-C

by Shuzhen Zhu, Bin Deng, Zifeng Huang, Zihan Chang, Hualin Li, Hui Liu, Yanjun Huang, Ying Pan, Yanping Wang, Yin-Xia Chao, Ling-Ling Chan, Yih-Ru Wu, Eng-King Tan, Qing Wang
Published 2021-02-01

Stress and mindfulness in Parkinson’s disease – a survey in 5000 patients

by Anouk van der Heide, Anne E. M. Speckens, Marjan J. Meinders, Liana S. Rosenthal, Bastiaan R. Bloem, Rick C. Helmich
Published 2021-01-01

Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primate

by Erika Coletto, Iain R. Tough, Sara Pritchard, Atsuko Hikima, Michael J. Jackson, Peter Jenner, K. Ray Chaudhuri, Helen M. Cox, Mahmoud M. Iravani, Sarah Rose
Published 2021-01-01

Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson’s disease

by Alicia Flores-Cuadrado, Daniel Saiz-Sanchez, Alicia Mohedano-Moriano, Elena Lamas-Cenjor, Victor Leon-Olmo, Alino Martinez-Marcos, Isabel Ubeda-Bañon
Published 2021-01-01

Pallidal stimulation as treatment for camptocormia in Parkinson’s disease

by Yijie Lai, Yunhai Song, Daoqing Su, Linbin Wang, Chencheng Zhang, Bomin Sun, Jorik Nonnekes, Bastiaan R. Bloem, Dianyou Li
Published 2021-01-01

The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study

by Megan P. Feeney, Yaqian Xu, Matthew Surface, Hiral Shah, Nora Vanegas-Arroyave, Amanda K. Chan, Elizabeth Delaney, Serge Przedborski, James C. Beck, Roy N. Alcalay
Published 2021-01-01

Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy

by Joachim Brumberg, Nils Schröter, Ganna Blazhenets, Lars Frings, Jens Volkmann, Constantin Lapa, Wolfgang H. Jost, Ioannis U. Isaias, Philipp T. Meyer
Published 2020-12-01

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy

by Souvarish Sarkar, Michael A. Murphy, Eric B. Dammer, Abby L. Olsen, Srikant Rangaraju, Ernest Fraenkel, Mel B. Feany
Published 2020-12-01

The CloudUPDRS smartphone software in Parkinson’s study: cross-validation against blinded human raters

by Ashwani Jha, Elisa Menozzi, Rebecca Oyekan, Anna Latorre, Eoin Mulroy, Sebastian R. Schreglmann, Cosmin Stamate, Ioannis Daskalopoulos, Stefan Kueppers, Marco Luchini, John C. Rothwell, George Roussos, Kailash P. Bhatia
Published 2020-12-01

Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20

by Briana R. De Miranda, Emily M. Rocha, Sandra L. Castro, J. Timothy Greenamyre
Published 2020-12-01

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD

by A. Castrioto, S. Thobois, M. Anheim, J. L. Quesada, E. Lhommée, H. Klinger, A. Bichon, E. Schmitt, F. Durif, J. P. Azulay, J. L. Houeto, N. Longato, C. Philipps, P. Pelissier, E. Broussolle, E. Moro, C. Tranchant, V. Fraix, P. Krack, for the Honeymoon study group
Published 2020-12-01

Palliative care for Parkinson’s disease: suggestions from a council of patient and carepartners

by Kirk Hall, Malenna Sumrall, Gil Thelen, Benzi M. Kluger, on behalf of the 2015 Parkinson’s Disease Foundation sponsored “Palliative Care and Parkinson’s Disease” Patient Advisory Council
Published 2017-05-01

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?

by Madelyn C. Houser, Malú G. Tansey
Published 2017-01-01

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial

by Howard E. Gendelman, Yuning Zhang, Pamela Santamaria, Katherine E. Olson, Charles R. Schutt, Danish Bhatti, Bhagya Laxmi Dyavar Shetty, Yaman Lu, Katherine A. Estes, David G. Standaert, Elizabeth Heinrichs-Graham, LuAnn Larson, Jane L. Meza, Matthew Follett, Erica Forsberg, Gary Siuzdak, Tony W. Wilson, Carolyn Peterson, R. Lee Mosley
Published 2017-03-01

Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease

by Dominic J Hare, Bárbara Rita Cardoso, Erika P Raven, Kay L Double, David I Finkelstein, Ewa A Szymlek-Gay, Beverley-Ann Biggs
Published 2017-01-01

The Gordon Research Seminar & Conference on Parkinson’s disease: state of the Science 200 years after James Parkinson’s essay on the Shaking Palsy

by J. T. Greenamyre, B. R. De Miranda, M. L. Bucher, A. B. Singleton, M. G. Tansey
Published 2017-08-01

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

by Per Odin, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist
Published 2018-05-01

LRRK2 levels in immune cells are increased in Parkinson’s disease

by D. A. Cook, G. T. Kannarkat, A. F. Cintron, Laura M. Butkovich, Kyle B. Fraser, J. Chang, N. Grigoryan, S. A. Factor, Andrew B. West, J. M. Boss, M. G. Tansey
Published 2017-03-01

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson’s disease (LARGE-PD), a case of ancestry

by Mario Cornejo-Olivas, Luis Torres, Mario R. Velit-Salazar, Miguel Inca-Martinez, Pilar Mazzetti, Carlos Cosentino, Federico Micheli, Claudia Perandones, Elena Dieguez, Victor Raggio, Vitor Tumas, Vanderci Borges, Henrique B. Ferraz, Carlos R. M. Rieder, Artur Shumacher-Schuh, Carlos Velez-Pardo, Marlene Jimenez-Del-Rio, Francisco Lopera, Jorge Chang-Castello, Brennie Andreé-Munoz, Sarah Waldherr, Dora Yearout, Cyrus P. Zabetian, Ignacio F. Mata
Published 2017-06-01

Validation of the XDP–MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism

by Paul Matthew D. Pasco, Roland Dominic G. Jamora, Raymond L. Rosales, Cid Czarina E. Diesta, Arlene R. Ng, Rosalia A. Teleg, Criscely L. Go, Lillian Lee, Hubert H. Fernandez
Published 2017-07-01